Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 15 May 2024 17:47:06 +0200Wed, 28 Feb 2024 15:10:00 +0100Opinion/decision on a Paediatric investigation plan (PIP): Reagila, Cariprazine (hydrochloride), decision type: RPM: decision refers to a refusal on the application for modification of an agreed PIP, therapeutic area: Psychiatry, PIP number: P/0061/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001652-pip01-14-m04Opinion/decision on a Paediatric investigation plan (PIP): Reagila, Cariprazine (hydrochloride), decision type: RPM: decision refers to a refusal on the application for modification of an agreed PIP, therapeutic area: Psychiatry, PIP number: P/0061/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001652-pip01-14-m04Wed, 28 Feb 2024 15:10:00 +0100Human medicine